Embecta Investor Relations Material
Latest events
Q1 2024
Embecta
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Embecta Corp
Access all reports
Embecta Corp is a medical device company that focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. The company's products include pen needles, syringes, and safety devices; as well as digital applications to assist people with managing their diabetes. Embecta Corp. sells its products to wholesalers, distributors, and increasingly directly to consumers through its online store. Founded in 1924 and based in Parsippany, New Jersey, Embecta Corp. Embecta operates independently of Becton, Dickinson and Company as of April 1, 2022.
Key slides for Embecta Corp
Q1 2024
Embecta Corp
Q1 2024
Embecta Corp
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States